{"title":"老鼠身上有痒的特征。","authors":"Tsugunobu Andoh, Mami Suzuki, Jung-Bum Lee","doi":"10.1097/FBP.0000000000000855","DOIUrl":null,"url":null,"abstract":"<p><p>In our clinical study, we found that itching had many different expressions (or qualities), including 'muzumuzu' (creepy-crawly itching, somewhat like tickling) and 'itch like mosquito bites'. Therefore, we investigated whether there were behavioral differences in response to different pruritogens in mice. In addition, we compared the behavioral characteristics of spontaneous scratching in mice with atopic-like dermatitis. In this study, we used six pruritogens [histamine, 5-hydroxytryptamine (5-HT), substance P, α-melanocyte-stimulating hormone (α-MSH), protease-activated receptor 2 agonist Ser-Leu-Ile-Gly-Arg-Leu-NH2 (SLIGRL), and chloroquine]. Pruritogen was intradermally injected into the rostral back skin of institute of cancer research (ICR) mice. Nishiki-nezumi Cinnamon/Nagoya (NC/Nga) mice infected with mites were used as animal model of atopic dermatitis (dermatitis NC/Nga mice). Their behavior was recorded using a digital video camera. The number of scratching behaviors was divided according to the presence or absence of precursor behaviors, such as shivering and body grooming-like behavior with the forelimbs, to scratching behaviors. Intradermal injection of histamine and substance P induced scratching without precursor behavior. On the other hand, intradermal injection of 5-HT and α-MSH-induced scratching after precursor behaviors. SLIGRL elicited scratching both with and without precursor behavior. In dermatitis NC/Nga mice, spontaneous scratching was induced mainly following precursor behaviors. These results suggest that itch-related behavior in mice is also characterized by the type of itching. Itching in atopic dermatitis is resistant to antihistamines. In this study, we demonstrated that the characteristics of histamine-induced scratching and dermatitis-induced spontaneous itching are different. This suggests that behavioral analyses may be useful for developing drugs to treat itching caused by diseases.</p>","PeriodicalId":8832,"journal":{"name":"Behavioural Pharmacology","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Presence of itch qualities in mice.\",\"authors\":\"Tsugunobu Andoh, Mami Suzuki, Jung-Bum Lee\",\"doi\":\"10.1097/FBP.0000000000000855\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In our clinical study, we found that itching had many different expressions (or qualities), including 'muzumuzu' (creepy-crawly itching, somewhat like tickling) and 'itch like mosquito bites'. Therefore, we investigated whether there were behavioral differences in response to different pruritogens in mice. In addition, we compared the behavioral characteristics of spontaneous scratching in mice with atopic-like dermatitis. In this study, we used six pruritogens [histamine, 5-hydroxytryptamine (5-HT), substance P, α-melanocyte-stimulating hormone (α-MSH), protease-activated receptor 2 agonist Ser-Leu-Ile-Gly-Arg-Leu-NH2 (SLIGRL), and chloroquine]. Pruritogen was intradermally injected into the rostral back skin of institute of cancer research (ICR) mice. Nishiki-nezumi Cinnamon/Nagoya (NC/Nga) mice infected with mites were used as animal model of atopic dermatitis (dermatitis NC/Nga mice). Their behavior was recorded using a digital video camera. The number of scratching behaviors was divided according to the presence or absence of precursor behaviors, such as shivering and body grooming-like behavior with the forelimbs, to scratching behaviors. Intradermal injection of histamine and substance P induced scratching without precursor behavior. On the other hand, intradermal injection of 5-HT and α-MSH-induced scratching after precursor behaviors. SLIGRL elicited scratching both with and without precursor behavior. In dermatitis NC/Nga mice, spontaneous scratching was induced mainly following precursor behaviors. These results suggest that itch-related behavior in mice is also characterized by the type of itching. Itching in atopic dermatitis is resistant to antihistamines. In this study, we demonstrated that the characteristics of histamine-induced scratching and dermatitis-induced spontaneous itching are different. This suggests that behavioral analyses may be useful for developing drugs to treat itching caused by diseases.</p>\",\"PeriodicalId\":8832,\"journal\":{\"name\":\"Behavioural Pharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Behavioural Pharmacology\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://doi.org/10.1097/FBP.0000000000000855\",\"RegionNum\":4,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BEHAVIORAL SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavioural Pharmacology","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1097/FBP.0000000000000855","RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
In our clinical study, we found that itching had many different expressions (or qualities), including 'muzumuzu' (creepy-crawly itching, somewhat like tickling) and 'itch like mosquito bites'. Therefore, we investigated whether there were behavioral differences in response to different pruritogens in mice. In addition, we compared the behavioral characteristics of spontaneous scratching in mice with atopic-like dermatitis. In this study, we used six pruritogens [histamine, 5-hydroxytryptamine (5-HT), substance P, α-melanocyte-stimulating hormone (α-MSH), protease-activated receptor 2 agonist Ser-Leu-Ile-Gly-Arg-Leu-NH2 (SLIGRL), and chloroquine]. Pruritogen was intradermally injected into the rostral back skin of institute of cancer research (ICR) mice. Nishiki-nezumi Cinnamon/Nagoya (NC/Nga) mice infected with mites were used as animal model of atopic dermatitis (dermatitis NC/Nga mice). Their behavior was recorded using a digital video camera. The number of scratching behaviors was divided according to the presence or absence of precursor behaviors, such as shivering and body grooming-like behavior with the forelimbs, to scratching behaviors. Intradermal injection of histamine and substance P induced scratching without precursor behavior. On the other hand, intradermal injection of 5-HT and α-MSH-induced scratching after precursor behaviors. SLIGRL elicited scratching both with and without precursor behavior. In dermatitis NC/Nga mice, spontaneous scratching was induced mainly following precursor behaviors. These results suggest that itch-related behavior in mice is also characterized by the type of itching. Itching in atopic dermatitis is resistant to antihistamines. In this study, we demonstrated that the characteristics of histamine-induced scratching and dermatitis-induced spontaneous itching are different. This suggests that behavioral analyses may be useful for developing drugs to treat itching caused by diseases.
期刊介绍:
Behavioural Pharmacology accepts original full and short research reports in diverse areas ranging from ethopharmacology to the pharmacology of schedule-controlled operant behaviour, provided that their primary focus is behavioural. Suitable topics include drug, chemical and hormonal effects on behaviour, the neurochemical mechanisms under-lying behaviour, and behavioural methods for the study of drug action. Both animal and human studies are welcome; however, studies reporting neurochemical data should have a predominantly behavioural focus, and human studies should not consist exclusively of clinical trials or case reports. Preference is given to studies that demonstrate and develop the potential of behavioural methods, and to papers reporting findings of direct relevance to clinical problems. Papers making a significant theoretical contribution are particularly welcome and, where possible and merited, space is made available for authors to explore fully the theoretical implications of their findings. Reviews of an area of the literature or at an appropriate stage in the development of an author’s own work are welcome. Commentaries in areas of current interest are also considered for publication, as are Reviews and Commentaries in areas outside behavioural pharmacology, but of importance and interest to behavioural pharmacologists. Behavioural Pharmacology publishes frequent Special Issues on current hot topics. The editors welcome correspondence about whether a paper in preparation might be suitable for inclusion in a Special Issue.